1. Diringer, MN, Bleck, TP, Claude Hemphill, J, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the neurocritical care society’s multidisciplinary consensus conference. Neurocrit Care. 2011;15:211-240.
Google Scholar | Crossref | Medline | ISI2. Francoeur, CL, Mayer, SA. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care. 2016;20:277. doi:10.1186/s13054-016-1447-6.
Google Scholar | Crossref | Medline3. Lannes, M, Zeiler, F, Guichon, C, Teitelbaum, J. The use of milrinone in patients with delayed cerebral ischemia following subarachnoid hemorrhage: a systematic review. Can J Neurol Sci. 2017;44:152-160.
Google Scholar | Crossref | Medline4. Barrett, LK, Singer, M, Clapp, LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med. 2007;35(1):33-40.
Google Scholar | Crossref | Medline5. Muehlschlegel, S, Dunser, MW, Gabrielli, A, Wenzel, V, Layon, AJ. Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage. Neurocrit Care. 2007;6:3-10.
Google Scholar | Crossref | Medline | ISI6. Marr, N, Yu, J, Kutsogiannis, DJ, Mahmoud, SH. Risk of hyponatremia in patients with aneurysmal subarachnoid hemorrhage treated with exogenous vasopressin infusion. Neurocrit Care. 2017;26:182-190.
Google Scholar | Crossref | Medline7. Connolly, ES, Rabinstein, AA, Carhuapoma, JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2012;43:1711-1737.
Google Scholar | Crossref | Medline | ISI8. Aleksandrowicz, M, Klapczynska, K, Kozniewska, E. Dysfunction of the endothelium and constriction of the isolated rat’s middle cerebral artery in low sodium environment in the presence of vasopressin. Clin Exp Pharmacol Physiol. 2020;47:759-764.
Google Scholar | Crossref | Medline9. Naranjo, CA, Busto, U, Sellers, EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245.
Google Scholar | Crossref | Medline | ISI10. Kane-Gill, SL, Kirisci, L, Pathak, DS. Are the naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit? Ann Pharmacother. 2005;39(11):1823-1827.
Google Scholar | SAGE Journals | ISI11. Hasan, D, Lindsay, KW, Wijdicks, EF, et al. Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke. 1989;20:1156-1161.
Google Scholar | Crossref | Medline | ISI12. Mori, T, Katayama, Y, Kawamata, T, Hirayama, T. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 1999;91(6):947-952.
Google Scholar | Crossref | Medline13. Koźniewska, E, Gadamski, R, Klapczyńska, K, Wojda, R, Rafałowska, J. Morphological changes in the brain during experimental hyponatraemia. Do vasopressin and gender matter? Folia Neuropathol. 2008;46(4):271-277.
Google Scholar | Medline14. Sladek, CD, Somponpun, SJ. Estrogen receptors: their roles in regulation of vasopressin release for maintenance of fluid and electrolyte homeostasis. Front Neuroendocrinol. 2008;29(1):114-127.
Google Scholar | Crossref | Medline15. Ayus, JC, Achinger, SG, Arieff, A. Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia. Am J Physiol Renal Physiol. 2008;295(3):F619-F624.
Google Scholar | Crossref | Medline16. Russell, JA, Walley, KR, Singer, J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877-887.
Google Scholar | Crossref | Medline | ISI17. Hajjar, LA, Vincent, JL, Barbosa Gomes Galas, FR, et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial. Anesthesiology. 2017;126(1):85-93.
Google Scholar | Crossref | Medline18. Kravetz, D, Bosch, J, Terés, J, Bruix, J, Rimola, A, Rodés, J. Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology. 1984;4(3):442-446.
Google Scholar | Crossref | Medline19. Mapa, B, Taylor, BES, Appelboom, G, Bruce, EM, Claassen, J, Connolly, ES. Impact of hyponatremia on morbidity, mortality, and complications after aneurysmal subarachnoid hemorrhage: a systematic review. World Neurosurg. 2016;85:305-314.
Google Scholar | Crossref | Medline20. Rabinstein, AA, Bruder, N. Management of hyponatremia and volume contraction. Neurocrit Care. 2011;15(2):354-360.
Google Scholar | Crossref | Medline21. Hajjar, LA, Zambolim, C, Belletti, A, et al. Vasopressin Versus norepinephrine for the management of septic shock in cancer patients: the VANCS II randomized clinical trial. Crit Care Med. 2019;47(12):1743-1750.
Google Scholar | Crossref | Medline22. Gordon, AC, Mason, AJ, Thirunavukkarasu, N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock. the VANISH randomized clinical trial. J Am Med Assoc. 2016;316(5):509-518.
Google Scholar | Crossref | Medline23. Fernandez, SJ, Barakat, I, Ziogas, J, et al. Association of copeptin, a surrogate marker of arginine vasopressin, with cerebral vasospasm and delayed ischemic neurologic deficit after aneurysmal subarachnoid hemorrhage. J Neurosurg 2019;130:1446-1452.
Google Scholar | Crossref24. Zhu, X-D, Chen, J-S, Zhou, F, Liu, Q-C, Chen, G, Zhang, J-M. Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage. Crit Care. 2011;15(6):R288. doi:10.1186/cc10575.
Google Scholar | Crossref | Medline25. Hannon, M, Thompson, C. Neurosurgical hyponatremia. J Clin Med. 2014;3(4):1084-1104.
Google Scholar | Crossref | Medline26. Hoffman, H, Ziechmann, R, Gould, G, Chin, LS. The impact of aneurysm location on incidence and etiology of hyponatremia following subarachnoid hemorrhage. World Neurosurg. 2018;110:e621-e626.
Google Scholar | Crossref | Medline27. Mather, HM, Ang, V, Jenkins, JS. Vasopressin in plasma and CSF of patients with subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry. 1981;44(3):216-219.
Google Scholar | Crossref | Medline28. Liu, Z-w, Gu, H, Zhang, B-f, et al. Rapidly increased vasopressin promotes acute platelet aggregation and early brain injury after experimental subarachnoid hemorrhage in a rat model. Brain Res. 2016;1639:108-119.
Google Scholar | Crossref | Medline